Delivery Order SPE2DB22D2206-SPE2DB23FKK09
- Not listed
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $17,179.37 and has an ultimate completion date of March 7, 2024. The award was made on March 6, 2024, and there was no set-aside...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The $41,340.92 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 28, 2024, with a completion date of February 29, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $21,217.81 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 1, 2024 with a completion date of March 4, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a ceiling value of $33,757.80 and a period of performance through April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor and has also been awarded an indefinite delivery contract (IDC) by DLA with a potential value of...
- This federal contract award, with a value of $11,495.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TREMFYA 100 MG/ML INJECTORML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The $8,017.07 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 17, 2023, with a completion date of February 21, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC...
- This federal contract award, valued at $20,437.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML SYRINGE/ML, a medical product, under a Firm Fixed Price delivery order. The contract has a completion date of December 27, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,274.20, is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is...
- This federal contract award, valued at $13,675.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, and has a completion date of February 24, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $97,323.89 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a July 2024 completion date and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FKK09Delivery Order
This federal contract award is for the delivery of TREMFYA 100 MG/ML syringes, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution firm. The contract has a ceiling value of $38,513.66 and an ultimate completion date of September 19, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract was awarded on September 18, 2023 and was not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award appears to be a specific delivery order against that larger IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.5k | 9/18/23 |